1 year return (CAGR)
-34.50%
Lisata Therapeutics Inc. Exchange (NASDAQ, USD)
LSTA
1.50
+0.07 (+4.53%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-11.03%
5 year return (CAGR)
-39.56%
10 year return (CAGR)
-31.41%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
13.52M
Price/Sales
135.16
Ent value
6.11M
Price/Book
1.69
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
29.32%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.47 |
| Daily high | 1.53 |
| Daily low | 1.44 |
| Daily Volume | 25K |
| All-time high | 18187500.00 |
| 1y analyst estimate | 4.00 |
| Beta | 0.88 |
| EPS (TTM) | -1.61 |
| Dividend per share | 0.00 |
| Ex-div date | 28 Oct 2013 |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| LSTA | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.38% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 24 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -94.62% | -10.68% |
| Avg time to new high | 546 days | 12 days |
| Max time to new high | 7679 days | 1805 days |
News
